Exact Mass: 483.12441420000005
Exact Mass Matches: 483.12441420000005
Found 106 metabolites which its exact mass value is equals to given mass value 483.12441420000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicergoline
C24H26BrN3O3 (483.1157426000001)
Nicergoline is only found in individuals that have used or taken this drug. It is an ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease. [PubChem]Nicergoline acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation. Therefore the mechanism of Nicergoline is to increase vascular circulation in the brain, thereby enhancing the transmission of nerve signals across the nerve fibres, which secrete acetylcholine as a neural transmitter. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].
O-Ethyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate
C22H29NO9S (483.1562944000001)
O-Ethyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate is a fully acetylated thiocarbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. Constituent of Moringa oleifera (horseradish tree) (Moringaceae). N-[(4-hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside) is found in fats and oils, herbs and spices, and green vegetables.
Amrubicin
Baloxavir
C24H19F2N3O4S (483.10642780000006)
Clopidogrel acyl glucuronide
C21H22ClNO8S (483.07546020000007)
(+/-)-1,3-dihydroxy-2-<1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-methyl-2-butenyl>-10-methyl-9-acridone|acrimarine-M
N-[(4-hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside)
C22H29NO9S (483.1562944000001)
Nicergoline
C24H26BrN3O3 (483.1157426000001)
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.982 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.978 Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].
Cys Cys Cys Arg
C15H29N7O5S3 (483.13922240000005)
Cys Cys Lys Met
Cys Cys Met Lys
Cys Cys Met Gln
C16H29N5O6S3 (483.12798940000005)
Cys Cys Gln Met
C16H29N5O6S3 (483.12798940000005)
Cys Cys Arg Cys
C15H29N7O5S3 (483.13922240000005)
Cys Lys Cys Met
Cys Lys Met Cys
Cys Met Cys Lys
Cys Met Cys Gln
C16H29N5O6S3 (483.12798940000005)
Cys Met Lys Cys
Cys Met Gln Cys
C16H29N5O6S3 (483.12798940000005)
Cys Gln Cys Met
C16H29N5O6S3 (483.12798940000005)
Cys Gln Met Cys
C16H29N5O6S3 (483.12798940000005)
Cys Arg Cys Cys
C15H29N7O5S3 (483.13922240000005)
Lys Cys Cys Met
Lys Cys Met Cys
Lys Met Cys Cys
Met Cys Cys Lys
Met Cys Cys Gln
C16H29N5O6S3 (483.12798940000005)
Met Cys Lys Cys
Met Cys Gln Cys
C16H29N5O6S3 (483.12798940000005)
Met Lys Cys Cys
Met Gln Cys Cys
C16H29N5O6S3 (483.12798940000005)
Gln Cys Cys Met
C16H29N5O6S3 (483.12798940000005)
Gln Cys Met Cys
C16H29N5O6S3 (483.12798940000005)
Gln Met Cys Cys
C16H29N5O6S3 (483.12798940000005)
Arg Cys Cys Cys
C15H29N7O5S3 (483.13922240000005)
N-Acetyl-5-hydroxysulfapyridine glucuronide
C19H21N3O10S (483.0947606000001)
3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl](2-phenoxyethyl)amino]propiononitrile
(5-bromo-4-chloro-1H-indol-3-yl) hexadecanoate
C24H35BrClNO2 (483.15395400000006)
Amrubicin
A synthetic anthracycline antibiotic with molecular formula C25H25NO9. A specific inhibitor of topoisomerase II, it is used (particularly as the hydrochloride salt) in the treatment of cancer, especially lung cancer, where it is a prodrug for the active metabolite, ambrucinol. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
N-[(1R,2R)-2-amino-1,2-diphenylethyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea
C23H19F6N3S (483.1203806000001)
5-bromo-6-chloro-3-indoxyl palmitate
C24H35BrClNO2 (483.15395400000006)
5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine
C23H22FN5O4S (483.13764640000005)
Baloxavir
C24H19F2N3O4S (483.10642780000006)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
Piroxantrone hydrochloride
C21H27Cl2N5O4 (483.14400020000005)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
N-Acetyl-L-phenylalanyl-4-[difluoro(phosphono)methyl]-L-phenylalaninamide
C21H24F2N3O6P (483.13707180000006)
3-{6-[(8-Hydroxy-quinoline-2-carbonyl)-amino]-2-thiophen-2-YL-hexanoylamino}-4-oxo-butyri acid
C24H25N3O6S (483.14639900000003)
(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol
Azlocillin sodium
C20H22N5NaO6S (483.1188432000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Katimborine
C22H29NO11 (483.17405240000005)
A natural product found in Citropsis articulata.
3-[(4-Phenyl-1-piperazinyl)sulfonyl]benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
C24H25N3O6S (483.14639900000003)
N-(6-Methoxy-pyridazin-3-yl)-4-[3-(3-p-tolyl-acryloyl)-thioureido]-benzenesulfonamide
C22H21N5O4S2 (483.10349060000004)
1-[4-(4-bromophenyl)-2-thiazolyl]-N-(3-phenylpropyl)-4-piperidinecarboxamide
C24H26BrN3OS (483.0979846000001)
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[3-(4-fluorophenyl)-2,4-dioxo-1-thieno[3,2-d]pyrimidinyl]acetamide
C24H22FN3O5S (483.12641340000005)
1-(2,3-Dihydroindol-1-yl)-2-[[4-methyl-5-[4-(1-pyrrolidinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]ethanone
N-(9-ethyl-3-carbazolyl)-2-[5-(4-morpholinylsulfonyl)-2-thiophenyl]acetamide
3-acetamido-N-[4-(4-methylsulfonylphenyl)-2-thiazolyl]-3-phenyl-N-prop-2-enylpropanamide
4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide
C22H22ClN7O2S (483.12441420000005)
N-[2-[(2R,5S,6S)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6R)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6S)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6S)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6S)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
1-(2,5-difluorophenyl)-3-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[2-[(2R,5S,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
1-(2,5-difluorophenyl)-3-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
1-(2,5-difluorophenyl)-3-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
C22H27F2N3O5S (483.1639396000001)
N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
5-bromo-3-pyridinecarboxylic acid [(6aS,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinoline-9-yl]methyl ester
C24H26BrN3O3 (483.1157426000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C21H29N3O8S (483.16752740000004)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2-methyl-3-oxo-1-phenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C21H29N3O8S (483.16752740000004)
4,7-DI(4-Ethoxyphenyl)-6-(4-methoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
(Z)-N-[(4-Hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside)
C22H29NO9S (483.1562944000001)
Sermion
C24H26BrN3O3 (483.1157426000001)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
FTI-277 (hydrochloride)
C22H30ClN3O3S2 (483.14170200000007)
FTI-277 hydrochloride is an inhibitor of farnesyl transferase (FTase); a highly potent Ras CAAX peptidomimetic which antagonizes both H- and K-Ras oncogenic signaling. FTI-277 hydrochloride can inhibit hepatitis delta virus (HDV) infection.
(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-[4-({[ethoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C22H29NO9S (483.1562944000001)
6-[(1r)-1-[(3ar,8as)-6-bromo-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]propyl]-2-imino-1,3-dimethylpteridin-4-one
C22H26BrN7O (483.13820860000004)
12-bromo-6-hydroxy-4-[hydroxy(3h-imidazol-4-yl)methylidene]-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
C22H22BrN5O3 (483.09059220000006)